Compare MAA & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAA | FMS |
|---|---|---|
| Founded | 1977 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Misc Health and Biotechnology Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6B | 14.1B |
| IPO Year | 1994 | 1996 |
| Metric | MAA | FMS |
|---|---|---|
| Price | $132.22 | $23.27 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 20 | 2 |
| Target Price | ★ $155.30 | $30.00 |
| AVG Volume (30 Days) | ★ 890.7K | 480.2K |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | ★ 4.60% | 2.45% |
| EPS Growth | 6.34 | ★ 8.62 |
| EPS | ★ 4.71 | 2.86 |
| Revenue | $2,203,402,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $1.82 | $2.12 |
| Revenue Next Year | $2.24 | $2.92 |
| P/E Ratio | $27.93 | ★ $15.86 |
| Revenue Growth | 0.92 | ★ 2.10 |
| 52 Week Low | $125.75 | $22.05 |
| 52 Week High | $173.38 | $30.46 |
| Indicator | MAA | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 37.10 |
| Support Level | $134.18 | $22.51 |
| Resistance Level | $136.95 | $24.20 |
| Average True Range (ATR) | 1.99 | 0.30 |
| MACD | 0.16 | 0.09 |
| Stochastic Oscillator | 27.43 | 45.27 |
Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.